Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Fractional exhaled NO and serum pneumoproteins after swimming in a chlorinated pool.

Carbonnelle S, Bernard A, Doyle IR, Grutters J, Francaux M.

Med Sci Sports Exerc. 2008 Aug;40(8):1472-6. doi: 10.1249/MSS.0b013e3181733159.

PMID:
18614944
2.
3.

Hypercapnic acidosis modulates inflammation, lung mechanics, and edema in the isolated perfused lung.

De Smet HR, Bersten AD, Barr HA, Doyle IR.

J Crit Care. 2007 Dec;22(4):305-13. Epub 2007 Mar 30.

PMID:
18086401
4.

Stretch and CO2 modulate the inflammatory response of alveolar macrophages through independent changes in metabolic activity.

Lang CJ, Barnett EK, Doyle IR.

Cytokine. 2006 Mar 21;33(6):346-51. Epub 2006 May 19.

PMID:
16713281
5.

Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction.

De Pasquale CG, Arnolda LF, Doyle IR, Aylward PE, Russell AE, Bersten AD.

Clin Exp Pharmacol Physiol. 2005 Aug;32(8):622-7.

PMID:
16120188
6.

Effect of CO2 on LPS-induced cytokine responses in rat alveolar macrophages.

Lang CJ, Dong P, Hosszu EK, Doyle IR.

Am J Physiol Lung Cell Mol Physiol. 2005 Jul;289(1):L96-L103. Epub 2005 Mar 18.

7.

Plasma surfactant protein-B: a novel biomarker in chronic heart failure.

De Pasquale CG, Arnolda LF, Doyle IR, Aylward PE, Chew DP, Bersten AD.

Circulation. 2004 Aug 31;110(9):1091-6. Epub 2004 Aug 9.

PMID:
15302797
8.

Determinants of serum levels of surfactant proteins A and B and Clara cell protein CC16.

Hermans C, Dong P, Robin M, Jadoul M, Bernard A, Bersten AD, Doyle IR.

Biomarkers. 2003 Nov-Dec;8(6):461-71.

PMID:
15195678
9.

Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema.

De Pasquale CG, Arnolda LF, Doyle IR, Grant RL, Aylward PE, Bersten AD.

Crit Care Med. 2003 Apr;31(4):1060-7.

PMID:
12682473
10.
11.

Infarct-induced chronic heart failure increases bidirectional protein movement across the alveolocapillary barrier.

De Pasquale CG, Bersten AD, Doyle IR, Aylward PE, Arnolda LF.

Am J Physiol Heart Circ Physiol. 2003 Jun;284(6):H2136-45. Epub 2003 Feb 6.

12.

Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects.

Robin M, Dong P, Hermans C, Bernard A, Bersten AD, Doyle IR.

Eur Respir J. 2002 Nov;20(5):1152-61.

13.

Endotoxin induces respiratory failure and increases surfactant turnover and respiration independent of alveolocapillary injury in rats.

Davidson KG, Bersten AD, Barr HA, Dowling KD, Nicholas TE, Doyle IR.

Am J Respir Crit Care Med. 2002 Jun 1;165(11):1516-25.

PMID:
12045126
14.

Elevated plasma surfactant protein-B predicts development of acute respiratory distress syndrome in patients with acute respiratory failure.

Bersten AD, Hunt T, Nicholas TE, Doyle IR.

Am J Respir Crit Care Med. 2001 Aug 15;164(4):648-52.

PMID:
11520731
15.

Intracrystalline proteins and the hidden ultrastructure of calcium oxalate urinary crystals: implications for kidney stone formation.

Lyons Ryall R, Fleming DE, Doyle IR, Evans NA, Dean CJ, Marshall VR.

J Struct Biol. 2001 Apr;134(1):5-14.

PMID:
11469872
16.

Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis.

Seymour JF, Presneill JJ, Schoch OD, Downie GH, Moore PE, Doyle IR, Vincent JM, Nakata K, Kitamura T, Langton D, Pain MC, Dunn AR.

Am J Respir Crit Care Med. 2001 Feb;163(2):524-31.

PMID:
11179134
17.

Lung function, permeability, and surfactant composition in oleic acid-induced acute lung injury in rats.

Davidson KG, Bersten AD, Barr HA, Dowling KD, Nicholas TE, Doyle IR.

Am J Physiol Lung Cell Mol Physiol. 2000 Dec;279(6):L1091-102.

18.

Composition of alveolar surfactant changes with training in humans.

Doyle IR, Morton S, Crockett AJ, Barr HA, Davidson KG, Jones MJ, Jones ME, Nicholas TE.

Respirology. 2000 Sep;5(3):211-20.

PMID:
11022982
19.

ARDS: nothing new?

Bersten AD, Doyle IR.

Med J Aust. 2000 Jun 5;172(11):527-8. No abstract available.

PMID:
10920748
20.

Pulmonary alveolar proteinosis: two contrasting cases.

Crocker HL, Pfitzner J, Doyle IR, Hague WM, Smith BJ, Ruffin RE.

Eur Respir J. 2000 Feb;15(2):426-9.

21.

Plasma surfactant protein-B is elevated in infants with respiratory syncytial virus-induced bronchiolitis.

Wang SZ, Doyle IR, Nicholas TE, Forsyth KD.

Pediatr Res. 1999 Dec;46(6):731-4.

PMID:
10590031
23.

Partitioning lung and plasma proteins: circulating surfactant proteins as biomarkers of alveolocapillary permeability.

Doyle IR, Nicholas TE, Bersten AD.

Clin Exp Pharmacol Physiol. 1999 Mar;26(3):185-97. Review.

PMID:
10081613
24.

Measurement of tidal volume by using transthoracic impedance variations in rats.

Davidson KG, Bersten AD, Nicholas TE, Ravenscroft PR, Doyle IR.

J Appl Physiol (1985). 1999 Feb;86(2):759-66.

25.

Clearance of Clara cell secretory protein 16 (CC16) and surfactant proteins A and B from blood in acute respiratory failure.

Doyle IR, Hermans C, Bernard A, Nicholas TE, Bersten AD.

Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1528-35.

PMID:
9817704
26.

Respiratory mechanics and surfactant in the acute respiratory distress syndrome.

Bersten AD, Davidson K, Nicholas TE, Doyle IR.

Clin Exp Pharmacol Physiol. 1998 Nov;25(11):955-63. Review.

PMID:
9807672
27.

Surfactant composition reflects lung overinflation and arterial oxygenation in patients with acute lung injury.

Bersten AD, Doyle IR, Davidson KG, Barr HA, Nicholas TE, Kermeen F.

Eur Respir J. 1998 Aug;12(2):301-8.

28.

Quantity and structure of surfactant proteins vary among patients with alveolar proteinosis.

Doyle IR, Davidson KG, Barr HA, Nicholas TE, Payne K, Pfitzner J.

Am J Respir Crit Care Med. 1998 Feb;157(2):658-64.

PMID:
9476887
29.

Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure.

Doyle IR, Bersten AD, Nicholas TE.

Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 1):1217-29.

PMID:
9351625
30.

Surfactant replacement therapy in ARDS: white knight or noise in the system?

Nicholas TE, Doyle IR, Bersten AD.

Thorax. 1997 Feb;52(2):195-7.

31.

Differential changes in SP-A and disaturated phospholipids in the isolated perfused rat lung and in vivo.

Doyle IR, Barr HA, Davidson KG, Nicholas TE.

Am J Physiol. 1996 Sep;271(3 Pt 1):L374-82.

PMID:
8843785
32.

Expression and distribution of surfactant proteins and lysozyme after prolonged hyperpnea.

Yogalingam G, Doyle IR, Power JH.

Am J Physiol. 1996 Mar;270(3 Pt 1):L320-30.

PMID:
8638723
33.

Serum surfactant protein-A levels in patients with acute cardiogenic pulmonary edema and adult respiratory distress syndrome.

Doyle IR, Nicholas TE, Bersten AD.

Am J Respir Crit Care Med. 1995 Jul;152(1):307-17.

PMID:
7599839
35.

Distribution of surfactant protein A in rat lung.

Doyle IR, Barr HA, Nicholas TE.

Am J Respir Cell Mol Biol. 1994 Oct;11(4):405-15.

PMID:
7917309
36.

Composition of human pulmonary surfactant varies with exercise and level of fitness.

Doyle IR, Jones ME, Barr HA, Orgeig S, Crockett AJ, McDonald CF, Nicholas TE.

Am J Respir Crit Care Med. 1994 Jun;149(6):1619-27.

PMID:
8004321
37.
38.

Immunohistochemical distribution and quantification of crystal matrix protein.

Stapleton AM, Seymour AE, Brennan JS, Doyle IR, Marshall VR, Ryall RL.

Kidney Int. 1993 Oct;44(4):817-24.

39.

Supplemental Content

Loading ...
Support Center